Naradja Wissmar: Raised IL-32 as a Hint to Long-Term Immune Activation Post-COVID
Naradja Wissmar, Former Administrator at Karolinska Institute, shared on LinkedIn:
”University of Milan teams found SARS-CoV-2 exposure raised blood IL 32, an inflammatory cytokine, and levels stayed high at least 1 year after severe COVID 19, hinting at lingering immune activation and a biomarker for long term effects.”
Title: Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
Authors: Lorenzo Miano, Elena Sinopoli, Alessandro Cherubini, Chiara Suffritti, Serena Pelusi, Fatima Rahmeh, Giuseppe Enzo Lamorte, Flora Peyvandi, Francesco Blasi, Giacomo Grasselli, Alessandra Bandera, Roberta Gualtierotti, Daniele Prati, Luca Vittorio Carlo Valenti
Read the Full Article on Frontiers
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 1, 2026, 15:24John Chuback: DVT Can Start With Symptoms Many People Brush Off
-
Jun 1, 2026, 15:20Venugopalan Unni: Guidelines for the Evaluation and Management of Acute Pulmonary Embolism in Adults
-
Jun 1, 2026, 15:10Smitirupa Mishra: Standardizing RBC Morphology Reporting – Why ICSH Guidelines Matter?
-
Jun 1, 2026, 14:54Davide Massimi: A Bloodless Approach to Third Space Endoscopy
-
Jun 1, 2026, 14:27Afshan Sumera: Plasma Proteomics Reveals Complement And Coagulation Disruption In Transfusion-Dependent Thalassemia
-
Jun 1, 2026, 13:44Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
-
Jun 1, 2026, 13:39Abdul Mannan: The Moral Injury of Practising Haemato-Oncology in a Resource-Limited Setting
-
Jun 1, 2026, 13:34Filza Aslam: What Does a Patient Journey Partner Actually Do in Bleeding Disorders?
-
Jun 1, 2026, 13:33Darine Ghanem: Advancing Health Equity in Care at the LATAM Meeting